Compare Tri Chemical Laboratories Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 16.41%
2
Company has very low debt and has enough cash to service the debt requirements
3
Healthy long term growth as Net Sales has grown by an annual rate of 20.20%
4
Flat results in Apr 26
5
With ROE of 16.68%, it has a expensive valuation with a 2.60 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
26.82%
0%
26.82%
6 Months
25.95%
0%
25.95%
1 Year
4.82%
0%
4.82%
2 Years
-20.18%
0%
-20.18%
3 Years
31.82%
0%
31.82%
4 Years
58.98%
0%
58.98%
5 Years
3.57%
0%
3.57%
Tri Chemical Laboratories Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
20.20%
EBIT Growth (5y)
17.19%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.55
Tax Ratio
25.13%
Dividend Payout Ratio
20.62%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.25%
ROE (avg)
16.41%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.60
EV to EBIT
13.94
EV to EBITDA
11.00
EV to Capital Employed
2.67
EV to Sales
3.70
PEG Ratio
0.31
Dividend Yield
NA
ROCE (Latest)
19.15%
ROE (Latest)
16.68%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Apr'26 - QoQ
Apr'26
Jan'26
Change(%)
Net Sales
7,488.70
5,872.80
27.51%
Operating Profit (PBDIT) excl Other Income
2,673.70
1,922.50
39.07%
Interest
22.60
15.50
45.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,855.40
1,493.60
24.22%
Operating Profit Margin (Excl OI)
276.30%
228.30%
4.80%
USD in Million.
Net Sales
QoQ Growth in quarter ended Apr 2026 is 27.51% vs 4.21% in Jan 2026
Consolidated Net Profit
QoQ Growth in quarter ended Apr 2026 is 24.22% vs 19.99% in Jan 2026
Annual Results Snapshot (Consolidated) - Jan'26
Jan'26
Jan'25
Change(%)
Net Sales
23,883.20
18,905.90
26.33%
Operating Profit (PBDIT) excl Other Income
7,819.70
6,628.90
17.96%
Interest
150.50
23.70
535.02%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,515.20
4,962.00
11.15%
Operating Profit Margin (Excl OI)
247.10%
278.00%
-3.09%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2026 is 26.33% vs 68.11% in Jan 2025
Consolidated Net Profit
YoY Growth in year ended Jan 2026 is 11.15% vs 100.84% in Jan 2025
About Tri Chemical Laboratories Inc. 
Tri Chemical Laboratories Inc.
Diversified
No Details Available.
Company Coordinates 
No Company Details Available






